AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 230 filers reported holding AMICUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $118,598,905 | +7.1% | 9,442,588 | -5.4% | 0.14% | +2.2% |
| Q1 2023 | $110,732,552 | +107467.9% | 9,984,901 | +18.4% | 0.14% | -7.4% |
| Q4 2022 | $102,942 | -99.7% | 8,430,952 | +141.9% | 0.15% | +175.9% |
| Q3 2022 | $36,387,000 | +426.8% | 3,485,302 | +442.0% | 0.05% | +440.0% |
| Q2 2022 | $6,907,000 | +76.4% | 643,082 | +55.5% | 0.01% | +150.0% |
| Q1 2022 | $3,916,000 | -19.6% | 413,469 | -2.0% | 0.00% | -20.0% |
| Q4 2021 | $4,872,000 | +29.8% | 421,817 | +7.3% | 0.01% | +25.0% |
| Q3 2021 | $3,754,000 | – | 393,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |